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Abstract Eggs and oocytes have a prominent ability to
reprogram sperm nuclei for ensuring embryonic develop-
ment. The reprogramming activity that eggs/oocytes
intrinsically have towards sperm is utilised to reprogram
somatic nuclei injected into eggs/oocytes in nuclear
transfer (NT) embryos. NT embryos of various species can
give rise to cloned animals, demonstrating that eggs/
oocytes can confer totipotency even to somatic nuclei.
However, many studies indicate that reprogramming of
somatic nuclei is not as efficient as that of sperm nuclei. In
this review, we explain how and why sperm and somatic
nuclei are differentially reprogrammed in eggs/oocytes.
Recent studies have shown that sperm chromatin is epi-
genetically modified to be adequate for early embryonic
development, while somatic nuclei do not have such
modifications. Moreover, epigenetic memories encoded in
sperm chromatin are transgenerationally inherited, imply-
ing unique roles of sperm. We also discuss whether somatic
nuclei can be artificially modified to acquire sperm-like
chromatin states in order to increase the efficiency of
nuclear reprogramming.
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Introduction
During the course of development, totipotent embryonic
cells differentiate and become committed to distinct lin-
eages. Once a cell is differentiated, it cannot be dedif-
ferentiated in normal development. However, it was
proved that it is possible to dedifferentiate a cell experi-
mentally in a process called cloning. Successful cloning
experiments have been first performed in Xenopus laevis:
when cells from embryos/tadpoles were transferred into
enucleated eggs, arrested at the metaphase of the second
meiotic division (MII; the term ‘‘MII egg’’ is used in
frogs, while ‘‘MII oocyte’’ is used for mammals), healthy
embryos with the genetic material of the donor cells were
generated, reaching adulthood and sexual maturity [1].
Decades later, Dolly the sheep was born as the first
mammalian somatic cell nuclear transfer (SCNT) animal
[2], followed by reports of successfully cloned individuals
across many mammalian species, including the mouse [3],
cow [4], goat [5], pig [6, 7], cat [8], rabbit [9], horse [10],
rat [11], dog [12], ferret [13], red deer [14], and camel
[15]. However, regardless of the species used, embryos
obtained by SCNT develop to the adulthood inefficiently
compared to embryos obtained by fertilisation. Further-
more, it is generally regarded that the more differentiated
somatic cell nuclei are when used as donors in SCNT, the
less efficient the process is; for example, in frogs, when
blastula or gastrula nuclei were used as donors for SCNT,
36 % of resulting embryos were able to develop to
feeding tadpoles, whereas when the nuclei of intestinal
epithelium were used, only 1.5 % embryos reached a
feeding tadpole stage [16]. Although this rule may not be
fully applied to mammalian cloning [17, 18], it is still
valid to conclude that embryonic cells are a better source
for SCNT [19].
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Why is SCNT inefficient or, in other words, why are
somatic cells resistant to reprogramming? The sperm
which fertilises the egg is also a highly specialised cell.
However, despite being specialised, its nucleus can almost
invariably support normal embryonic development.
Therefore, the specialisation of the sperm that occurs
during spermatogenesis prepares it to undergo efficient
reprogramming by the egg after fertilisation. Namely, the
sperm is developmentally ‘programmed’ to be ‘repro-
grammed’ and to sustain normal embryonic development.
In this review we first describe sperm ‘programming’: we
review the important nuclear changes occurring during
spermatogenesis that allow the mature sperm to acquire its
unique chromatin features. Secondly, we discuss which of
the unique sperm features may be responsible for the high
efficiency of embryonic development after fertilisation,
with a focus on protein and RNA contents, as well as on
epigenetic modifications present on the chromatin of the
mature sperm. Thirdly, we describe reprogramming events
occurring upon NT in order to compare them to those
occurring at fertilization. Thereafter, we summarise the
most commonly observed abnormalities in cloned
embryos, which are largely attributed to features of somatic
cell chromatin. Lastly, we focus on the main differences
between sperm and somatic cells that are likely related to
reprogramming efficiency and discuss possible ways of
improving cloning efficiency by making somatic cells more
sperm-like.
Unique features of sperm chromatin
Sperm specialisation occurs during spermatogenesis as a
series of precisely controlled events changing a progenitor
germ cell into a spermatozoon. The length of the process,
as well as the precise mechanisms controlling each step of
spermatogenesis, differs amongst vertebrates, though gen-
eral concepts are similar [20]. Somatic precursors of sperm
cells, spermatogonia (developed from male germ cells),
can undergo either a proliferative or a differentiative cell
division. The former produces more spermatogonial cells,
the latter results in the formation of a spermatogonial cell
and a primary spermatocyte [21]. Primary spermatocytes
enter meiotic division, producing secondary spermatocytes,
which, upon completion of the meiotic division, form
spermatids [20]. Spermatids have the number of chromo-
somes and the DNA content already reduced and do not
undergo any other divisions. However, they resemble
somatic cells morphologically, as well as at the molecular
level, and in order to transform into highly specialised
mature sperm they have to complete a series of substantial
structural and morphological changes, called spermiogen-
esis [22] (Fig. 1).
Changes in the nuclear composition
One of the most striking changes occurring during sper-
miogenesis is the compaction of the sperm nucleus. Inter-
estingly, it has been calculated that the volume of DNA of
mouse sperm is six times smaller than the DNA in mitotic
chromosomes [23]. The high condensation of sperm DNA
is possibly due to the presence of protamines. Protamines
are small and highly basic proteins that become incorpo-
rated into the chromatin during spermiogenesis in place of
core histones that are the major component of the chro-
matin in spermatids [24]. The process of protamine
incorporation is complex and requires many intermediate
steps. Firstly, histone variants are thought to be incorpo-
rated alongside canonical histones, which are subsequently
modified post-translationally and replaced by transition
proteins (explained later) [25, 26]. Eventually, transition
proteins are replaced by protamines, which are the major
chromatin component of the mature sperm (Fig. 1). Fur-
thermore, there are a lot of other changes occurring: tran-
scription ceases, and a lot of proteins disappear from the
maturing sperm nucleus whereas others are specifically
accumulated. Below, we briefly describe our current
understanding of nuclear changes occurring during
spermiogenesis.
Histone variants and histone modifications
As mentioned above, incorporation of histone variants is
the first major event allowing the nuclear maturation of a
spermatid. There are numerous histone variants expressed
specifically in testis, for example H2A.lap and H2A.Bbd as
variants of histone H2A [27, 28], TH2B as a variant of
H2B [29, 30], H1t and Hils1 as variants of H1 [31, 32] or
H3t as a variant of histone H3 [33]. It has been shown that
H2A.lap1 marks transcriptional start sites of specific tran-
scripts expressed during spermatogenesis [28]. Interest-
ingly, other histone variants are thought to facilitate
incorporation of protamines. In vitro studies, in which
nucleosomes have been assembled with testis-specific
histone variants (H3t, TH2B, H2A.L2) and with somatic-
type histones, indicate that such combinatorial nucleo-
somes are unstable [34–36]. Therefore, it is hypothesized
that when these histones start to be expressed during
spermatogenesis they form nucleosomes with somatic-like
histones present in the spermatids. This, in turn, confers the
instability of such combinatorial nucleosomes and allows
the incorporation of transition proteins [37]. Furthermore,
the instability of histone-containing nucleosomes can also
be due to the presence of post-translational modifications
that can alter the chromatin-binding properties. Such
modifications can be present not only on core histones, but
also on testis-specific histone variants [38–40]. One of the
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most striking and the best described changes in histone
post-translational modifications is a wave of core histone
acetylation during spermiogenesis. Immunohistochemical
studies revealed that acetylated forms of H2A, H2B, H3
and H4 are present specifically in elongating spermatids
(no acetylation in round spermatids and no acetylation in
mature sperm), suggesting that the transient presence of
this mark may be implicated in exchange of histones to
protamines and condensation of sperm DNA (Fig. 1) [41].
Further studies led to the identification of a protein, named
Brdt (Bromodomain testis-specific), which specifically
binds to acetylated lysine residues on histone H4 [42, 43].
Studies using mammalian culture cells ectopically
expressing Brdt have shown that its binding to acetylated
histones leads to chromatin compaction [42]. It has been
also demonstrated that Brdt remodels chromatin in an
ATP-independent way and that it interacts with Smarce1,
which is a member of SWI/SNF remodelling complex [44].
Importantly, male mice lacking Brdt are infertile and have
abnormal, misshapen sperm [45], suggesting that Brdt
binding to acetylated histones may be indeed a crucial step
allowing a proper condensation of sperm chromatin.
Transition proteins and protamines
Apart from histones and their modifications, other factors
which are implicated in protamine deposition are transition
proteins. Global histone acetylation precedes their
appearance [37]. There are two transition proteins: transi-
tion protein 1 (TP1) and transition protein 2 (TP2). Their
function is redundant, since mice with deletion of TP1 or
TP2 alone are fertile (albeit with a reduced fertility) [46,
47]. However, knockout of both TP1 and TP2 results in
infertile mice with abnormal sperm [26], suggesting that
Fig. 1 Major chromatin
changes during spermiogenesis.
In order to achieve a sperm-like
chromatin state, the round
spermatid which enters the
spermiogenesis process
undergoes a series of chromatin
remodelling events. First,
canonical core histones packing
the chromatin in the round
spermatid can be replaced by
histone variants, which together
with global histone acetylation,
leads to instability of the
nucleosome structure.
Subsequently, transition
proteins are incorporated in
place of unstable nucleosomes
in the elongating spermatid.
Finally, transition proteins are
replaced with protamines. The
mature sperm chromatin is
mainly composed of
protamines, with interspersed
histones and with tightly
associated mRNAs and
transcription factors. All these
processes are occurring in
parallel with the cessation of
transcription—round spermatids
are transcriptionally active,
whereas no transcription is
detected in the mature sperm
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transition proteins are important for a proper spermato-
genesis. Finally, the protamines, which replace transition
proteins towards the end of spermiogenesis, are also
essential for male fertility. It has been demonstrated that
even heterozygous male mice, which are mutant for prot-
amine 1 or protamine 2, are infertile [48]. Detailed analyses
of protamine 2 mutant mice revealed that haploinsuffi-
ciency of protamine 2 affected the DNA integrity of the
mature sperm [49]. Interestingly, abnormal levels or
mutations of protamines also correlate with infertility in
humans [50, 51].
Cessation of transcription and disappearance of basal
transcriptional machinery
Spermiogenesis is however not only a process leading to
the acquisition of unique sperm-specific proteins. Numer-
ous proteins typical for somatic cells disappear in the
course of spermiogenesis. The most remarkable is the
disappearance of RNA polymerase II and hence, cessation
of transcription in maturing spermatids; round spermatids
are actively transcribing, while there is no transcription in
mature sperm (Fig. 1) [52]. The same happens to basal
transcription factors: TAF1 and TLF (TBP-like factor) also
disappear during spermatid condensation [53–55]. There-
fore, it could be that cessation of transcription and removal
of the majority of basal transcriptional machinery is
important for the paternal nucleus to sustain the embryonic
gene expression pattern after fertilization.
Which components of the sperm make
it ‘programmed’ to be ‘reprogrammed’?
Since there are numerous factors being acquired and lost
during sperm maturation (Fig. 1), it is not easy to dissect
the ones that are responsible for rendering the sperm easily
reprogrammable by eggs/oocyte, as opposed to the somatic
cell after nuclear transfer. We can however classify them
into five categories: (1) protamines, (2) sperm-derived
transcriptional regulators, (3) sperm-derived RNAs, (4)
post-translational modification of histones in the mature
sperm, and (5) DNA methylation profiles in the mature
sperm. We will discuss below the potential involvement of
each of these categories in making sperm easily
reprogrammable.
Protamines
One of the biggest differences between sperm and somatic
cells is the fact that DNA of a somatic cell is wrapped
around histones, whereas DNA of sperm is tightly packed
by protamines. Containing protamines instead of canonical
histones can have at least two roles in facilitating the
reprogramming at fertilisation. Firstly, after fertilisation,
the protamines from the sperm are removed by an egg/
oocyte with the aid of a maternal protein called nucleo-
plasmin [56–59]. Subsequently, oocyte-derived histones
are incorporated into paternal DNA to allow the assembly
of chromatin [60, 61]. On the other hand, a somatic cell
does not have protamines, and hence it may be more dif-
ficult for the transplanted somatic cell to exchange its
histones for the oocyte-derived ones. In addition, somatic
cell histones often bear post-translational modifications
associated with active gene states, according to the lineage
from which the cell is originated. As a result, some genes
characteristic for that lineage could continue to be inap-
propriately expressed in the embryo. Indeed, it has been
shown in Xenopus that upon NT of somatic cells derived
from somites (muscle precursors expressing a gene called
MyoD), resulting embryos continued to aberrantly express
MyoD (discussed in the later section) [62]. Therefore, it is
tempting to speculate that having protamines instead of
histones may be beneficial for sperm to erase the devel-
opmental program which is often encoded in histone
marks: this is because at fertilisation protamines are effi-
ciently replaced with oocyte-derived histones and because
the newly incorporated histones are likely to be modified
according to the embryonic developmental program.
Indeed, it has been shown that embryos derived from round
spermatid injection (round spermatids do not yet have
protamines deposited on their chromatin) display epige-
netic abnormalities as compared to embryos obtained by
mature sperm injection (which do have protamines on their
DNA): round spermatid-derived embryos have been shown
to have elevated DNA methylation levels and histone
H3K9me3 marks present on the paternal chromatin, which
are not normally observed in sperm-derived embryos [63].
Apart from these potential roles of protamines in efficient
histone exchange, the presence of protamines on sperm
DNA and its tight packaging likely protects the DNA from
any physical damage. It has been shown that in rabbits in
which no offspring could be derived after the protamine-
free round spermatid injection, the developmental arrest is
likely due to abnormal ploidy of the resulting embryos
[64]. Similarly, during the NT procedure somatic cells are
exposed to numerous micromanipulations, and because
they do not have protamines tightly protecting their DNA,
these procedures could lead to DNA damage. In fact, it has
been suggested that one of the major causes of develop-
mental arrest of NT embryos is a result of DNA loss [65],
which might be a consequence of DNA damage. With the
current state of knowledge it is therefore difficult to dis-
criminate whether the presence of protamines on the DNA
helps to epigenetically program the paternal chromatin for
embryonic development or whether it prevents the DNA
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from physical damage (or both). In addition, it has been
shown that even though the embryonic development after
round spermatid injection is generally less efficient than the
development after sperm injection, it can reproducibly give
rise to normal offspring in several species [66–70], sug-
gesting that the chromatin of round spermatid, even though
it is not protaminated, can support full term development.
However, since mice deficient with protamines are infertile
[48], having protamines on the DNA is clearly beneficial
for the development and hence the lack of protamines
might be one of the explanations for the low efficiency of
SCNT.
Sperm-derived transcriptional regulators
As mentioned before, it has been demonstrated that
towards the end of spermiogenesis, transcription ceases and
components of the basal transcriptional machinery disap-
pear [55]. However, it has also been shown that the mature
sperm contains transcription factors (Oct-1, Ets-1, C/EBP
and TBP) associated with the hypersensitive regions of
chromatin [71] (Fig. 1). It is therefore likely that such
chromatin-associated factors could be delivered to the
oocyte at fertilization. Furthermore, proteomic analysis of
the mature sperm led to the identification of more proteins
which are involved in transcriptional regulation, for
example, Bromodomain-containing protein 7 (Brd7) or
Polycomb protein Suz12 [72]. Upon delivery to the oocyte,
these factors might help to pattern gene expression char-
acteristic for the developing embryo. In contrast, a somatic
cell during a nuclear transfer procedure may deliver tran-
scriptional regulators responsible for the maintenance of its
own differentiated cell state to the oocyte. This might
interfere with normal embryonic gene expression since the
embryo requires factors enabling the establishment of
totipotency and not cell-type specific, differentiation fac-
tors. In fact, injection of the somatic cell cytoplasm into
oocytes impairs normal development of fertilised embryos
and indeed it has been demonstrated that such embryos
have decreased expression levels of pluripotency factor
Oct4 [73].
Sperm-derived RNAs
It has been recently discovered that mature sperm, despite
having a very low amount of cytoplasm, carries numerous
mRNAs [74], including mRNAs encoding transcription
factors, for example cMyc [75]. These mRNAs have been
shown to be delivered to the oocyte after fertilisation [76].
What is the role of these sperm-derived mRNAs? It is
currently not well understood, but there are several
hypotheses. The first one suggests that these mRNAs
remain tightly associated with sperm chromatin and can
somehow protect some regions of the sperm DNA from
protamination. As a result, this would allow histone
retention on these regions. Such protamine-free regions
could be then selectively activated in the developing
embryo (see section below) [74]. A second hypothesis is
that RNA stored in the sperm can exert influence on the
gene expression profile of the resulting embryo. It could be
either by providing mRNA which serves as a template for
synthesis of transcription factors important for embryo-
genesis, such as cMyc, or by inducing paramutations.
Paramutation is a heritable epigenetic change resulting in a
mutant phenotype in the absence of the actual genetic
mutation. For example, it has been shown that wild type
progeny of mice generated from heterozygous fathers
harbouring a mutation in a cKit gene (demonstrated with a
white tail phenotype) also have white tails. This paramu-
tation was shown to be induced by antisense RNA carried
over to the oocyte by the sperm at fertilisation [77]. It is
also possible that sperm-derived RNA can be directly
involved in regulating embryonic development. Indeed, it
has been recently shown that sperm-borne microRNA-34c
is required for the first cleavage division of the mouse
embryo by directly regulating antiproliferative protein Bcl2
[78]. Therefore, there is evidence that carry-over sperm
RNA can influence the pattern of embryonic gene expres-
sion and even phenotypes of the progeny. Such instructive
information about embryonic development in a form of
RNAs is likely to be absent or altered in somatic cells
(presence of somatic-cell specific RNAs), therefore
affecting the normality of embryonic development after
NT.
Post-translational modifications of histones
in the mature sperm
Another explanation for why the sperm so efficiently
supports embryonic development can be due to the pres-
ence of particular post-translational modifications on his-
tones retained in mature sperm. As explained before,
towards the end of spermiogenesis, histones are replaced
with protamines. However, it has been recently shown that
both in mice and in humans some histones remain in the
mature sperm [79, 80]. It has also been described that both
in mouse and in human, sperm-derived histones (at least
some of them) are transmitted to the oocyte at fertilization
and retained in the paternal pronucleus [61, 81, 82].
Moreover, retention of histones in the mature sperm is
nonrandom; namely, histones are retained at promoter
regions of developmentally important genes. Furthermore,
these retained histones bear epigenetic marks and their
patterns correlate well with future embryonic gene
expression: genes with an activating mark, H3K4me3, are
switched on early in development, whereas genes with a
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repressive mark, H3K27me3, are either repressed or acti-
vated late [79, 80]. Interestingly, this phenomenon has also
been observed in species in which sperm is not protami-
nated (core histones are the major component of chromatin
in the mature gamete). For example, in zebrafish, which
does not have protamines, developmentally important
promoters also have signatures of H3K4me3 and
H3K27me3, which correlate with future embryonic gene
expression [83, 84]. Interestingly, it has been described that
infertile patients have abnormal histone retention profiles
[85]. All these suggest that sperm may be able to provide
the embryo with a ‘patterning’ message, encoded in its
histone marks, as to which genes should be expressed and
when during embryogenesis. Sperm of infertile patients,
which do not have this message (or have incorrect mes-
sages), cannot support proper embryonic development.
Such lack of the correct patterning message could also
explain inefficient embryonic development after nuclear
transfer. Somatic cells have their epigenetic marks on
histones established according to their own developmental
profile, and those epigenetic marks are likely different from
those of embryos.
DNA methylation profiles in the mature sperm
Another epigenetic feature of the mature sperm that may
render it suitable to support embryonic development is
DNA methylation. Cytosine in DNA can be methylated,
which leads to creation of 5-methylcytosine. Methylated
cytosines are often associated with gene repression [86–
90], whereas unmethylated cytosines usually mark trans-
criptionally active genes [91, 92]. Differential cytosine
methylation is also observed at gene promoters in mature
sperm. Interestingly, cytosine methylation states in gene
promoters in sperm are very similar to those of embryonic
stem cells [93] and correlate with gene expression pat-
terns in the embryos. Genes whose promoters are unme-
thylated in the mature sperm are expressed early during
embryogenesis, whereas methylated genes are expressed
late or repressed in embryogenesis [79, 80, 84]. More-
over, there is a correlation between abnormal DNA
methylation patterns in the mature sperm and infertility in
humans [94]. Therefore, DNA methylation can be yet
another way for the sperm to contribute a developmental
message to the embryo, another way the sperm differs
from somatic cells, and which may explain the low effi-
ciency of SCNT. In fact, a recent genome-wide study
clearly indicates that DNA methylation patterns of SCNT
embryos resemble those of donor somatic genome rather
than those of the paternal genome of fertilised embryos
[95], suggesting that DNA methylation profiles are indeed
different between sperm-derived and somatic cell-derived
embryos.
Reprogramming of somatic nuclei in eggs and oocytes
We have so far discussed how sperm nuclei are efficiently
reprogrammed in eggs/oocytes. However, cloned embryos
are produced in a very different way from normal fertilised
embryos and also undergo unique reprogramming pro-
cesses. In this section we describe a series of reprogram-
ming events in cloned embryos. To produce a cloned
embryo, nuclear transplantation of a somatic nucleus to an
enucleated egg/oocyte is performed (Fig. 2). Eggs/oocytes
at the metaphase II (MII) stage are widely used as recipi-
ents for NT. Since the MII-arrested oocytes have a strong
maturation promoting factor (MPF) activity, the trans-
planted somatic nucleus undergoes nuclear envelope
breakdown and premature chromosome condensation
(PCC) (Fig. 2) [96, 97]. It seems that exposure of somatic
chromatin to the MII egg/oocyte cytoplasm is an important
determinant for successful reprogramming by increasing
the number of origins of DNA replication in order to
facilitate robust DNA replication cycles in embryos [98,
99]. It has also been postulated that PCC allows oocyte
reprogramming factors to gain access to somatic chromatin
since the barrier of nuclear envelopes disappears. Epige-
netic modifications on histone tails, such as deacetylation
and phosphorylation [100, 101], are also induced soon after
NT (within 2 h) (Fig. 2). Moreover, some core and linker
histones are rapidly removed from somatic chromatin or
exchanged to oocyte counterparts (Fig. 2). For example,
macroH2A, associated with repressive chromatin, is readily
removed after NT (Fig. 2) [102]. Subsequently, MII-
arrested NT oocytes are activated and start early embryonic
development. NT embryos then form pseudo-pronuclei,
where somatic chromatin undergoes extensive deconden-
sation (Fig. 2) [97]. In mouse, heterochromatin reorgani-
zation is induced in the pseudo-pronuclei of NT embryos
[103]. Additionally, active DNA demethylation of the
somatic genome is observed during the one-cell stage
(Fig. 2) [95, 104]. Histone modifications of the pseudo-
pronuclei are significantly different from those of original
somatic chromatin and more resemble those of fertilised
pronuclei, although quantitative differences of such histone
modifications have been reported [100, 105–107] (see
below). Towards the end of the first cell cycle in mouse,
transcriptional activators are gradually accumulated in
pronuclei (Fig. 2) [108] to allow major embryonic gene
activation at the 2 cell stage (Fig. 2). Subsequently, genes
required for pluripotency such as Oct4 and Nanog are
activated [109]. Once NT embryos have reached the blas-
tocyst stage, embryonic stem cells can be derived. It is
possible that reprogramming is continuing even at the
blastocyst stage because abnormal histone modifications
prominent at the early embryonic stages are corrected in
the blastocyst stage embryos [107].
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There are some alternative methods for NT. Oocytes at
the telophase stage and enucleated embryos at the one-cell
stage can also be used as recipients for NT as long as
pronuclear factors are not removed during enucleation
[110–112]. It is not clear whether reprogramming events
induced in these NTs are the same as the ones in NT to
metaphase II oocytes. Apart from these NTs, which can
support full-term development, somatic nuclei injected into
the giant nucleus of Xenopus oocytes at the meiotic pro-
phase I stage also known as the germinal vesicle (GV)
stage can be reprogrammed to express embryonic genes
[113]. This type of NT is adequate for analysing mecha-
nisms of transcriptional reprogramming [114, 115] since it
does not require cell divisions and new protein synthesis.
However, this type of NT does not support full term
development.
There are a few maternal factors known to be important
for development of NT embryos. For example, nucleoli in
mouse and porcine NT embryos are derived from the
nucleolus of the recipient oocyte [116]. When maternal
nucleoli are removed, NT embryos are deprived of nucleoli
and fail to develop. These results suggest that maternally
inherited nucleoli are necessary for development. Tpt1
protein is an example of another maternal factor important
for development of bovine NT embryos with the mecha-
nisms still unknown [117]. Additionally, a screen for
maternal factors required for reprogramming has identified
DJ-1 as a maternal protein required for development of
porcine NT embryos [118]. DJ-1 inhibits P53 activation in
NT embryos; this also suggests that P53 is prone to be
activated in NT embryos. Furthermore, it has been shown
that maternal Tet3-mediated hydroxymethylation is
induced in cloned mouse embryos [119] and is responsible
for DNA demethylation on the Oct4 promoter [120]. More
studies to identify maternal factors important for develop-
ment of cloned embryos are needed for understanding the
basis of egg/oocyte-mediated reprogramming.
Abnormalities in cloned embryos in relation to somatic
cell characteristics
A number of reprogramming events, discussed in the pre-
vious section, are induced in NT embryos. NT embryos
Fig. 2 Nuclear reprogramming in somatic cell nuclear transfer
embryos. A series of reprogramming events occurring in NT embryos
are depicted (mainly focusing on mouse NT embryos). A somatic
nucleus injected into an enucleated oocyte at the metaphase II stage
undergoes premature chromosome condensation (PCC). After acti-
vation, pseudo-pronuclei are formed. Transcription of embryonic
genes starts from the 2-cell stage. Cloned embryos can be implanted
to foster mothers and in most cases less than a few percentage of
embryos can develop to term. Histone modifications, histone variants,
DNA methylation, and chromatin proteins show dynamic changes
during preimplantation development. Many of them are important for
development of cloned embryos, but are abnormally regulated
compared to fertilised counterparts. Abnormal gene expression in
cloned embryos has also been reported. The numbers of abnormally
expressed genes are based on transcriptome studies of 2-cell embryos
[151, 152] and those for blastocyst embryos [150, 151, 156]
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that have successfully gone through these events can
achieve full-term development. However, it is often the
case that NT embryos fail to complete at least a part of
reprogramming events. In this section, we discuss what
kinds of errors are prone to occur in NT embryos during
reprogramming. We then relate the defective reprogram-
ming events in NT embryos to specific characteristics of
somatic chromatin.
DNA demethylation and histone modification
In mouse, upon fertilisation, sperm DNA undergoes active
and global demethylation during the one-cell stage. Low
methylation levels are maintained until the blastocyst
stage when global remethylation starts [121]. In cloned
embryos, the extent of DNA demethylation in the trans-
planted somatic nuclei is less than that in paternal pro-
nuclei [104]. Such abnormally high DNA methylation
states in cloned embryos have been found across many
mammalian species [104, 122, 123]. Bisulfite sequencing
analyses have revealed that high DNA methylation states
remain at the various genomic regions including the
centric and pericentric repeats [124] and the Oct4 regu-
latory regions [125, 126]. A recent genome-wide DNA
methylation study has identified more than 20 genes
whose DNA methylation remains abnormally high after
NT compared to fertilised embryos [95]. This study also
shows that some repetitive elements, such as long inter-
spersed elements (LINEs) and long terminal repeats
(LTRs), are resistant to DNA demethylation in cloned
embryos [95]. Since these genomic regions are efficiently
demethylated in paternal pronuclei, the refractory nature
towards DNA demethylation seems largely attributed to
somatic genomes.
Histone modifications of somatic cell chromatin are
dramatically changed after NT to oocytes [100, 101].
Although histone tails of somatic chromatin are repro-
grammed to resemble those of embryonic chromatin, a
number of abnormal histone modifications have been
reported in NT embryos [100, 105–107, 127]. Notably,
abnormally high levels of histone H3K9 methylation are
retained in NT embryos [100, 105, 107] and the high
H3K9 methylation is likely one of the reasons why
cloned embryos exhibit a low developmental capacity.
Indeed, removal of H3K9 methylation prior to NT
improves cloning efficiencies [128, 129] although causal
relationship between loss of H3K9 methylation and
reprogramming in NT embryos has to be further tested.
H3K9 methylation also restricts reprogramming in iPS
cells [130, 131], supporting the idea that somatic chro-
matin acquires H3K9 methylation to stabilize differenti-
ation states and hence to resist nuclear reprogramming. A
more targeted way of removing histone marks before NT,
such as locus-specific H3K9 methylation removal, may
further boost reprogramming efficiency. It has also been
shown that modulating histone acetylation levels by his-
tone deacetylase inhibitors can greatly improve cloning
efficiencies [17, 132–136]. For example, histone H4K5 in
NT embryos shows less acetylation than in fertilised
embryos [127] and this abnormal acetylation state can be
partially corrected by Trichostatin A treatment [137].
Furthermore, histone deacetylase inhibitors also improve
many aspects of reprogramming including transcription
and chromatin reorganization [100, 138, 139]. Histone
modifications on H3K27 play an important role in gene
regulation especially in relation with polycomb com-
plexes. Many somatic genes are repressed through
H3K27 methylation. After NT of somatic cells to
oocytes, higher H3K27 methylation [140] and lower
H3K27 acetylation [106] than in fertilised embryos are
observed in 1- and 2-cell stage embryos. In addition,
localisation of PRC2 components in cloned embryos is
significantly different from fertilised embryos [140] and
abnormal expression of polycomb-associated genes is
observed [141]. Trichostatin A treatment was shown to
increase a H3K27 acetylation level in cloned embryos to
the one of fertilised embryos [106]. It would be inter-
esting to see whether the elevated level of H3K27 acet-
ylation is linked to the improvement of other chromatin
signatures, such as H3K27 methylation and association of
polycomb complexes.
In addition to the above mentioned histone modifica-
tions, linker histones and histone variants show dynamic
changes upon NT of somatic cells to oocytes. The somatic
type linker histone H1 is rapidly exchanged with the
embryonic type linker histone B4/H1foo upon NT to
oocytes [142–144]. Incorporation of histone B4 into the
somatic chromatin creates accessible states of chromatin
[144, 145]. A recent study indicates that histone variants
H3.1, H3.2 and H3.3, as well as H2A and H2A.Z, are
rapidly removed from transplanted nuclei in mouse NT
embryos [146]. At the same time, oocyte-derived histone
H3 variants and H2AX are incorporated into the trans-
planted nuclei. Interestingly, abnormally high amounts of
H3.1 are incorporated into transplanted somatic nuclei
compared to fertilised embryos (Fig. 2) [146]. This might
be attributed to the features of donor chromatin that prefer
H3.1 incorporation for heterochromatin formation or by the
fact that chaperones for H3.1 can be carried over with the
donor cell. In accordance with the incorporation of oocyte-
derived H2AX into transplanted nuclei [146], phosphory-
lated H2AX (cH2AX) is found in pseudo-pronuclei of NT
embryos although the number of cH2AX foci is smaller
than that of fertilised embryos [147]. cH2AX in 1-cell
embryos is proposed to be associated with DNA repair and
DNA demethylation.
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Embryonic gene activation
Transcriptionally silent NT embryos start to express
embryonic genes from the time of zygotic genome acti-
vation (ZGA) onwards. Hundreds of embryonic genes that
are silenced in somatic cells can be activated in NT
embryos. However, many defects in properly turning on
embryonic genes have been reported [148–152]. Abnor-
mal gene expression in NT embryos is observed as early
as ZGA [151, 152]. Microarray analysis of 2-cell mouse
embryos has revealed that more than 2000 mRNAs are
misregulated in NT embryos compared to fertilised
embryos [152]. Transcription by RNA polymerase I is
also disturbed in cloned embryos around this stage [139,
153]. This early abnormal gene expression can be rescued
by treatment with histone deacetylase inhibitors [135,
139], suggesting that abnormal gene expression in early
embryos is at least partially due to the somatic epige-
nome, which is not adequate to support the embryonic
gene expression program. In fact, some somatic genes
continue to express in NT embryos at the 2 cell stage
[154]. Equally importantly, maternally stored transcripts
are not properly degraded in NT embryos [152]. This is
also true in rhesus-bovine interspecies NT embryos [155],
implying that inappropriate degradation of maternal
transcripts can cause a critical problem for subsequent
embryonic development. Although NT embryos tend to
display numerous abnormalities at the early develop-
mental stages, the number of abnormally expressed genes
in cloned embryos usually decreases at the blastocyst
stage [151, 156]. This could be partially because only
successfully reprogrammed embryos are able to reach the
blastocyst stage. Nevertheless, these results support the
idea that reprogramming is continued throughout early
embryonic development. However, there are some
embryonic genes that are resistant to reprogramming even
at the blastocyst stage, such as Oct4 [148] and Sox2
[150]. Abnormal expression of such important pluripo-
tency genes at this stage may severely affect subsequent
development after implantation.
Recently, large-scale transcriptome analyses have iden-
tified gene loci that are often abnormally regulated in
cloned blastocyst embryos [150, 157]. Genes in the ‘‘large
organized chromatin K9-modifications’’ (LOCKs) regions
are repressed in NT embryos. LOCKs are enriched with
histone H3K9me2, a repressive mark [158]. Differentiated
cells exhibit larger occupancy of the LOCKs in the genome
than embryonic cells [158]. Since H3K9 methylation is
difficult to remove in cloned embryos (see above), it is
plausible that H3K9 methylation in LOCKs of somatic
chromatin causes abnormal gene repression in NT
embryos. It would be interesting to test functional signifi-
cance of the abnormal gene repression associated with
LOCKs in NT embryos. Another set of abnormally regu-
lated genes is X chromosome-linked genes. This is due to
the ectopic expression of Xist from the active X chromo-
some [157]. Suppressing excess Xist RNA by gene
knockout [157] or siRNA-mediated knockdown [159]
greatly improves the cloning efficiency. These results
indicate that misregulation of a single important gene can
cause detrimental effects on development of cloned
embryos.
Epigenetic memory of somatic chromatin
in cloned embryos
As mentioned above, somatic-like chromatin states can
be transmitted to NT embryos and possibly result in
inappropriate gene expression. It is especially clear that
oocytes often fail to reverse silenced states of some
embryonic genes in transplanted somatic chromatin
because of layers of silencing mechanisms, including
DNA methylation and H3K9 methylation. Apart from
these types of reprogramming errors, there is evidence
that active states of somatic genes are inherited in cloned
embryos and the somatic type of gene expression con-
tinues in early embryos. In this section, we discuss
examples of such abnormal somatic gene expression. For
example, when myoblasts are used as donor cells for
mouse NT, the myoblast cloned embryos start to express
glucose transporter type 4 (Glut4), which is expressed in
muscles but not in normal preimplantation embryos, at
the late one-cell stage [154]. Similarly, the neuroecto-
dermal marker gene is ectopically expressed in the
endoderm cells in Xenopus NT embryos in which neu-
roectoderm nuclei are used as donors, and vice versa
[160]. Interestingly, premature transcription of such
somatic gene expression in NT embryos is also observed
[160], suggesting that NT embryos are incapable of
properly repressing some somatic genes of transplanted
nuclei. Ng and Gurdon [62] provide a mechanistic insight
into this epigenetic memory of somatic gene expression.
Upon NT of somatic cells derived from somites (muscle
precursors expressing a gene called MyoD), resulting
embryos continue to aberrantly express MyoD. It has
been shown that this memory of an active gene is
dependent on trimethylation of lysine 4 on histone H3.3
in the promoter region of MyoD [62]. Another study
proposes that a low level of histone H4K5 acetylation in
somatic chromatin is inherited in cloned embryos and
this may contribute to aberrant gene expression [127].
This idea needs to be further tested in individual genes
that carry H4K5 acetylation. It is possible that more
histone marks and chromatin proteins associated with
active states of somatic gene expression would be dis-
covered in future.
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Other abnormalities in cloned embryos
Apart from the above mentioned chromatin defects,
numerous other abnormalities have been reported in cloned
embryos and animals, including defective placentas [161,
162], mitochondria heteroplasmy [17, 163], obesity [164],
abnormal offspring syndrome [165], and short life spans
[166]. In this section, we introduce other critical defects of
cloned embryos, which are related to or derived from
characteristics of somatic cells. In fertilised 1-cell mouse
embryos, centromeres and pericentric heterochromatin
regions of chromosomes associate with the periphery of the
nucleolar precursor bodies [167, 168]. After NT of somatic
nuclei into oocytes, the somatic type of heterochromatin
often fails to be reprogrammed to the embryonic-like het-
erochromatin. Many cloned embryos show an abnormally
high number of centromeres that do not associate with
nucleolar precursor bodies [103]. Since centromeres are
crucial for chromosome segregation, such abnormal posi-
tioning of centromeres may result in abnormal distribution
of chromosomes to the daughter cells. In fact, cloned
embryos often show improper distribution of chromosomes
[169]. Recently, Mizutani et al. [65] demonstrated that
abnormal chromosome segregation during early embryonic
development is detrimental to full term development of
cloned embryos. In relation to the abnormal chromosome
segregation, somatic NT embryos exhibit abnormal spindle
chromosome complex formation [170, 171] and spindle
associating factors, such as calmodulin and NuMA, are
found to be less abundant in somatic cell cloned embryos
than in embryonic cell cloned embryos and fertilized
embryos [170, 171]. Since defects in chromosome segre-
gation seem to be one of the major causes of poor devel-
opment of cloned animals, it would be interesting to
determine to what extent abnormal heterochromatin and
spindle formation affect early chromosome segregation
defects.
Can we impose sperm-like states on somatic cells
to increase the cloning efficiency?
As described above, there are a lot of differences between
the sperm and somatic cells and each one of them, or a
combination of these differences, may explain the low
efficiency of cloning, as compared to efficient embryonic
development after fertilisation. An ultimate goal in the
reprogramming field is to increase the efficiency of animal
cloning. It is reasonable to think that imposing sperm-like
changes onto somatic cells will make them more prone to
reprogramming. However, is such an approach feasible? In
this section we discuss different possibilities of making
somatic cells more like sperm.
Protamines
As mentioned above, the presence of protamines in the
mature sperm is crucial for its ability to support correct
embryonic development for at least a couple of reasons.
Firstly, it may physically protect DNA from damage.
Secondly, it may help to remove the majority of histones
together with their marks and allow incorporation of
oocyte-derived ones. Therefore, one could speculate that
the easiest way to make a somatic cell more reprogram-
mable would be to wrap its DNA with protamines. How-
ever, it may be technically very challenging, because the
deposition of protamines onto sperm chromatin is a com-
plicated, multi-step process. It has been shown that
impairments of single stages of this process (for example,
removal of acetyl-lysine binding protein Brdt, or depletion
of transition proteins) are detrimental for the sperm matu-
ration and result in infertility [26, 45]. Therefore, in order
to correctly deposit protamines on somatic cells, it is likely
that one would not only need to introduce protamines into
somatic cells, but also recapitulate other events occurring
during spermiogenesis. Furthermore, this should be done in
a sequential manner. Firstly, histone variants need to be
expressed. The second step is to induce global histone
acetylation, followed by histone removal and transition
protein deposition. Introduction of protamines is only the
last stage of the process. To summarise, if one could
deposit protamines onto the chromatin of somatic cells, this
might be a step forward in increasing the cloning effi-
ciency. However, at the current state of methodology
available, the correct deposition of protamines seems to be
a technically challenging objective.
Carry-over proteins and RNAs
The mature sperm carries numerous proteins and RNAs
which, as discussed above, could also be a part of sperm
programming to support efficient embryonic development.
Therefore, the next possible way to increase the efficiency
of SCNT is to supply somatic cells with sperm proteins and
RNAs. This would be challenging if one wants to isolate
only the proteins and RNAs which are developmentally
relevant, since numerous proteins and RNAs have been
identified in the mature sperm and it is not well known
which, if any, are important for embryonic development
[72, 74]. A feasible approach is to isolate total protein and
RNA from sperm and co-inject them into an oocyte toge-
ther with a cell during the NT procedure. However, it
cannot be excluded that the developmentally important
proteins/RNAs are tightly associated with the sperm
chromatin [74]. If this is the case, isolation of these factors
could be technically demanding. Another approach is to
directly deliver sperm into NT oocytes in which somatic
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nuclei have been transplanted beforehand and subsequently
remove the paternal pronucleus from the cloned embryos.
This way, cloned oocytes are also activated by sperm
injection in a similar way to normal fertilisation [97, 172].
However, this method did not improve cloning efficiency
[172], which can be due to the fact that factors which are
developmentally important may remain tightly associated
with the sperm chromatin. Alternatively, enucleated early
zygotes, in which sperm contents are delivered into reci-
pient, can be used for NT [110, 111, 173].
Histone marks and DNA methylation
Another explanation for a sperm being superior to a
somatic cell in its reprogramming capacity could be the
unique pattern of its epigenetic modifications: histone and
DNA methylation marks present on sperm chromatin can
possibly pattern future embryonic gene expression. It is
likely that imposing sperm-like epigenetic changes onto
somatic cells would improve development of NT embryos.
However, at the current state of knowledge this approach
seems difficult. Firstly, so far the only genome-wide pro-
files in mouse and human sperm are available for
H3K4me3, H3K27me3, H4K12ac, and DNA methylation
[79, 80, 174]. It is known that epigenetic marks often work
in combination and there are many more marks known than
just these three; for example histone arginine methylation
[175–177] or recently identified histone crotonylation
[178]. It could be that the instructive information for
embryonic development is a complex combination of var-
ious marks at various loci. If one can identify specific
histone marks on a certain gene of sperm that are important
for subsequent development, it would be worth trying to
mimic such marks on somatic cell chromatin. Achieving
gene locus-specific modification is currently difficult.
However, with the development of zinc finger or TALE
protein targeting approaches [179–184], it might be pos-
sible to induce sperm-like histone modifications in a gene-
specific manner by targeting histone-modifying enzymes in
the future.
Changing somatic cells into sperm?
The breakthrough study by Yamanaka and Takahashi [185]
made it possible to derive pluripotent stem cells (iPS cells)
from somatic cells by overexpression of transcription fac-
tors. iPS cells can differentiate into any type of cell in the
body. Recently, Hayashi et al. [186] have succeeded in
making spermatozoa from iPS and ES cells, and the pro-
duced spermatozoa supported full-term development after
intracytoplasmic sperm injection. In theory it is therefore
possible to obtain functional spermatozoa from somatic
cells. However, this process requires multiple steps
including dedifferentiation to an embryonic state, redif-
ferentiation to primordial germ-like cells, and, ultimately,
spermatogenesis. In addition, the resulting spermatozoa are
haploid, carry paternal imprinting and require a maternal
genome for successful development. Furthermore, the
ultimate process of changing somatic cells into sperm—the
spermatogenesis itself, is achieved by transferring pri-
mordial germ-like cells into testis. Therefore, this route
may not be appropriate for the purpose of increasing
cloning efficiency. However, this might be useful to pro-
duce a sperm deprived of a specific sperm factor important
for subsequent development because gene knockdown or
knockout can be achieved efficiently in pluripotent stem
cells. An alternative route could be to directly change
somatic cells to sperm-like or sperm progenitor-like cells
by factor overexpression or extract treatment. This seems
extremely challenging. Nevertheless, some progress has
been made in inducing testis-specific gene expression in
somatic cells treated with testis extracts. These extract-
treated cells supported better development of cloned
embryos than control non-treated cells [187]. It would be
interesting to investigate why and how testis extract-treated
cells are better reprogrammed in eggs/oocytes.
Conclusions and perspectives
Recent advances in genetic and epigenetic analytic
approaches allowed the identification of some unique fea-
tures of sperm chromatin that are absent in somatic cells.
For example, histones are retained in sperm chromatin at
promoter regions of developmentally important genes for
subsequent gene expression in embryos. Such sperm
chromatin modifications are likely to support embryonic
development after fertilisation. Somatic chromatin does not
have such ‘‘fine-tuning’’ for correct embryonic gene
expression. Therefore, it is a likely explanation for why
SCNT embryos often show abnormal reprogramming
events compared to fertilised embryos. Somatic chromatin
features, such as epigenetic memory, often remain in
cloned embryos and can interfere with normal develop-
ment. Moreover, other non-chromatin related factors, such
as the presence of certain somatic-like transcription factors
or presence of somatic-like spindle associating factors, can
also impede the development of NT embryos. Therefore, it
is remarkable that cloned embryos can sometimes develop
to totally normal individuals. This is a good example
illustrating that early embryonic development is charac-
terised by both amazingly accurate programming and sur-
prising plasticity. Nevertheless, there must be some
essential requirements for the accomplishment of success-
ful embryonic development. Identification of such road-
blocks to development is a key challenge for
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developmental and reproductive biology. Studying differ-
ences between the sperm and somatic cells in respect to
their abilities to be reprogrammed by the eggs/oocytes
would help to unravel the key requirements for successful
development.
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